Nurix Therapeutics, Inc. NRIX Convertible Preferred Stock Outstanding Shares
Convertible Preferred Stock Outstanding Shares at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s convertible preferred stock outstanding shares.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s convertible preferred stock outstanding shares?
- Nurix Therapeutics, Inc. (NRIX) reported convertible preferred stock outstanding shares of 0 in Q4 2025.
- What does convertible preferred stock outstanding shares mean?
- This represents the total number of preferred equity shares that carry the right to be converted into common stock at a specified ratio. Monitoring this figure is essential for calculating fully diluted share counts and understanding potential future equity dilution for common shareholders.